200 related articles for article (PubMed ID: 6160000)
1. The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) F1 mice.
Adam C; Thoua Y; Ronco P; Verroust P; Tovey M; Morel-Maroger L
Clin Exp Immunol; 1980 May; 40(2):373-82. PubMed ID: 6160000
[TBL] [Abstract][Full Text] [Related]
2. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.
Okudaira H; Terada E; Okudaira K
Prog Clin Biol Res; 1987; 229():157-74. PubMed ID: 3601985
[TBL] [Abstract][Full Text] [Related]
3. Immunologic abnormality in NZB/NZW F1 mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individuals.
Mihara M; Ohsugi Y; Saito K; Miyai T; Togashi M; Ono S; Murakami S; Dobashi K; Hirayama F; Hamaoka T
J Immunol; 1988 Jul; 141(1):85-90. PubMed ID: 3259971
[TBL] [Abstract][Full Text] [Related]
4. Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW)F1 hybrid and the correlation to renal disease.
Maruyama N; Furukawa F; Nakai Y; Sasaki Y; Ohta K; Ozaki S; Hirose S; Shirai T
J Immunol; 1983 Feb; 130(2):740-6. PubMed ID: 6217253
[TBL] [Abstract][Full Text] [Related]
5. A murine nephritogenic monoclonal antibody binds to both single-stranded deoxyribonucleic acid and glomerulus.
Nagata N; Miyashima S; Taketani S; Toki J; Hosaka N; Tomita T; Fujishima H; Tokunaga R; Ikehara S
Lab Invest; 1994 Nov; 71(5):765-72. PubMed ID: 7967527
[TBL] [Abstract][Full Text] [Related]
6. Removal of glomerular deposits induced by either preformed immune complexes or by a chronic immune complex model in NZB/W mice.
Haakenstad AO
J Immunol; 1987 Jun; 138(12):4192-9. PubMed ID: 2953800
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of early thymic irradiation in (NZB x NZW)F1 mice, associated with a selective decrease in the levels of IgG3 and gp70-anti-gp70 immune complexes.
Erausquin C; Merino R; Izui S; Fernandez-Sueiro L; Saez F; Fernandez F; Rodriguez-Valverde V; Merino J
Cell Immunol; 1995 Apr; 161(2):207-12. PubMed ID: 7697731
[TBL] [Abstract][Full Text] [Related]
9. Administration of dehydroepiandrosterone sulfate retards onset but not progression of autoimmune disease in NZB/W mice.
Norton SD; Harrison LL; Yowell R; Araneo BA
Autoimmunity; 1997; 26(3):161-71. PubMed ID: 9550284
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ
Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
[TBL] [Abstract][Full Text] [Related]
11. Treatment with antibody reactive with the nephritogenic idiotype, IdLNF1, suppresses its production and leads to prolonged survival of (NZB x SWR)F1 mice.
Uner AH; Knupp CJ; Tatum AH; Gavalchin J
J Autoimmun; 1994 Feb; 7(1):27-44. PubMed ID: 8198700
[TBL] [Abstract][Full Text] [Related]
12. Genetic regulation of hypergammaglobulinaemia and the correlation to autoimmune traits in (NZB X NZW) F1 hybrid.
Hirose S; Sekigawa I; Ozaki S; Sato H; Shirai T
Clin Exp Immunol; 1984 Dec; 58(3):694-702. PubMed ID: 6334582
[TBL] [Abstract][Full Text] [Related]
13. Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice.
Dong L; Ito S; Ishii KJ; Klinman DM
Arthritis Rheum; 2005 Feb; 52(2):651-8. PubMed ID: 15692999
[TBL] [Abstract][Full Text] [Related]
14. Isoprinosine delays the early appearance of autoimmunity in NZB/NZW F1 mice treated with interferon.
Sergiescu D; Cerutti I; Kahan A; Piatier D; Efthymiou E
Clin Exp Immunol; 1981 Jan; 43(1):36-45. PubMed ID: 6166417
[TBL] [Abstract][Full Text] [Related]
15. Severity of glomerulonephritis induced in different strains of suckling mice by infection with lymphocytic choriomeningitis virus: correlation with amounts of endogenous interferon and circulating immune complexes.
Woodrow D; Ronco P; Riviere Y; Moss J; Gresser I; Guillon JC; Morel-Maroger L; Sloper JC; Verroust P
J Pathol; 1982 Dec; 138(4):325-36. PubMed ID: 6184462
[TBL] [Abstract][Full Text] [Related]
16. The contribution of I-Abm12 to phenotypic and functional alterations among T-cell subsets in NZB mice.
Naiki M; Yoshida SH; Watanabe Y; Izui S; Ansari AA; Gershwin ME
J Autoimmun; 1993 Apr; 6(2):131-43. PubMed ID: 8388689
[TBL] [Abstract][Full Text] [Related]
17. Effect of the B cell superantigen protein A from S. aureus on the early lupus disease of (NZBxNZW) F1 mice.
Viau M; Zouali M
Mol Immunol; 2005 May; 42(7):849-55. PubMed ID: 15829273
[TBL] [Abstract][Full Text] [Related]
18. Adverse effects of interferon treatment on the life span of NZB mice.
Sergiescu D; Cerutti I; Efthymiou E; Kahan A; Chany C
Biomedicine; 1979 Apr; 31(2):48-51. PubMed ID: 476279
[TBL] [Abstract][Full Text] [Related]
19. Sequential study of C 1 q-binding substances and of anti-DNA antibodies in (NZB X NZW)F1 mice: evidence for an acute phase of the lupus disease in 2-month-old mice.
Fournié GJ; Gayral-Ta Minh M; Haas S; Pourrat JP; Conte JJ
Eur J Immunol; 1979 Aug; 9(8):652-4. PubMed ID: 499331
[TBL] [Abstract][Full Text] [Related]
20. Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn) or cyclosporin A treated (NZB X NZW) F1 mice.
Israel-Biet D; Noel LH; Bach MA; Dardenne M; Bach JF
Clin Exp Immunol; 1983 Nov; 54(2):359-65. PubMed ID: 6360436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
